Devices for Cardiac Resynchronization
DOI: 10.1007/978-0-387-71167-6_20
|View full text |Cite
|
Sign up to set email alerts
|

How to Program CRT Devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Both SMART-AV (not significant) and SMART-CRT (P=0.03) showed a trend in improving left ventricular end-systolic volume (LVESV) [1,2]. Prof. Christophe Leclercq (Hospital Pontchaillou of Rennes, France) presented a pooled analysis that included participants from both trials who met the inclusion criteria for SMART-CRT: indication for cardiac resynchronisation therapy and right ventricular-left ventricular duration ≥70 ms [3]. The pooled analysis included 226 participants with algorithm-adapted atrioventricular delay and 225 participants in the fixed atrioventricular delay (120 ms) group.…”
Section: Smart-av and Smart-crt: Improved Cardiac Outcomes With Algor...mentioning
confidence: 99%
“…Both SMART-AV (not significant) and SMART-CRT (P=0.03) showed a trend in improving left ventricular end-systolic volume (LVESV) [1,2]. Prof. Christophe Leclercq (Hospital Pontchaillou of Rennes, France) presented a pooled analysis that included participants from both trials who met the inclusion criteria for SMART-CRT: indication for cardiac resynchronisation therapy and right ventricular-left ventricular duration ≥70 ms [3]. The pooled analysis included 226 participants with algorithm-adapted atrioventricular delay and 225 participants in the fixed atrioventricular delay (120 ms) group.…”
Section: Smart-av and Smart-crt: Improved Cardiac Outcomes With Algor...mentioning
confidence: 99%